Rui Ling

Global signatures of protein and mRNA expression levels

Progress and challenges towards targeted delivery of cancer therapeutics

A survey of best practices for RNA-seq data analysis

In silico prediction of protein-protein interactions in human macrophages

Breast cancer

Integrins in cancer: biological implications and therapeutic opportunities

Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbits

mRNA-based therapeutics — developing a new class of drugs

Use of new imaging techniques to predict tumour response to therapy

Delivery technologies for cancer immunotherapy

PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases

Targeted delivery of nanoparticles for the treatment of lung diseases

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

On the Dependency of Cellular Protein Levels on mRNA Abundance

Inhibitory effect of emodin on migration, invasion and metastasis of human breast cancer MDA-MB-231 cells in vitro and in vivo

Benefits, risks, and safety of external beam radiation therapy for breast cancer

Mucins in the pathogenesis of breast cancer: Implications in diagnosis, prognosis and therapy

Insights into the regulation of protein abundance from proteomic and transcriptomic analyses

Global quantification of mammalian gene expression control

Radiomics: the bridge between medical imaging and personalized medicine

Glycosylation in cancer: mechanisms and clinical implications

Multiple Roles of MicroRNA-100 in Human Cancer and its Therapeutic Potential

pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures

Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics

Deep proteome and transcriptome mapping of a human cancer cell line

Muc1 Immunotherapy

PEGylation Does Not Significantly Change the Initial Intravenous or Subcutaneous Pharmacokinetics or Lymphatic Exposure of Trastuzumab in Rats but Increases Plasma Clearance after Subcutaneous Administration

Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics

The Versatile Role of microRNA-30a in Human Cancer

Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells

A novel serum microRNA signature to screen esophageal squamous cell carcinoma

Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides

Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer

Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: A prospective randomized controlled multi-center trial

Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer

Effective anti-tumor responses induced by recombinant bacillus Calmette–Guérin vaccines based on different tandem repeats of MUC1 and GM-CSF

Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening

Lymphatic chemotherapy induces apoptosis in lymph node metastases in a rabbit breast carcinoma model

Immunization with two recombinant Bacillus Calmette-Guérin vaccines that combine the expression of multiple tandem repeats of mucin-1 and colony stimulating-factor suppress breast tumor growth in mice

Body Distribution of Nanoparticle-Containing Adriamycin Injected into the Hepatic Artery of Hepatoma-Bearing Rats

[Expression and activation of MAPK pathway signaling molecules in human breast cancer cell lines].

[Value of fused 18F-FDG PET/CT images in predicting efficacy of neoadjuvant chemotherapy on breast cancer].